347 related articles for article (PubMed ID: 28219961)
1. Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes.
Thorlacius L; Ingram JR; Garg A; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Christensen R; Jemec GB
BMJ Open; 2017 Feb; 7(2):e014733. PubMed ID: 28219961
[TBL] [Abstract][Full Text] [Related]
2. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.
Thorlacius L; Ingram JR; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Nielsen SM; Christensen R; Garg A; Jemec GBE;
Br J Dermatol; 2018 Sep; 179(3):642-650. PubMed ID: 29654696
[TBL] [Abstract][Full Text] [Related]
3. Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II.
Thorlacius L; Garg A; Ingram JR; Villumsen B; Theut Riis P; Gottlieb AB; Merola JF; Dellavalle R; Ardon C; Baba R; Bechara FG; Cohen AD; Daham N; Davis M; Emtestam L; Fernández-Peñas P; Filippelli M; Gibbons A; Grant T; Guilbault S; Gulliver S; Harris C; Harvent C; Houston K; Kirby JS; Matusiak L; Mehdizadeh A; Mojica T; Okun M; Orgill D; Pallack L; Parks-Miller A; Prens EP; Randell S; Rogers C; Rosen CF; Choon SE; van der Zee HH; Christensen R; Jemec GBE
Br J Dermatol; 2018 Mar; 178(3):715-721. PubMed ID: 29080368
[TBL] [Abstract][Full Text] [Related]
4. Surgical Handover Core Outcome Measures (SH-CORE): a protocol for the development of a core outcome set for trials in surgical handover.
Ryan JM; Devane D; Simiceva A; Eppich W; Kavanagh DO; Cullen C; Hogan AM; McNamara DA
Trials; 2024 Jun; 25(1):373. PubMed ID: 38858749
[TBL] [Abstract][Full Text] [Related]
5. Development of a Core Outcome Set for Studies on Obesity in Pregnant Patients (COSSOPP): a study protocol.
Dadouch R; Faheim M; Juando-Prats C; Parsons J; D'Souza R;
Trials; 2018 Nov; 19(1):655. PubMed ID: 30482249
[TBL] [Abstract][Full Text] [Related]
6. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
[TBL] [Abstract][Full Text] [Related]
7. IMMPACT-recommended outcome measures and tools of assessment in burning mouth syndrome RCTs: an international Delphi survey protocol.
Carey B; Farag AM; Nasri-Heir C; Klasser GD; Ariyawardana A; Chmieliauskaite M; Sardella A; Carlson CR; Miller CS; Mejia L; O'Neill FE; Albuquerque R
Trials; 2020 Aug; 21(1):711. PubMed ID: 32787910
[TBL] [Abstract][Full Text] [Related]
8. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
9. Developing a core outcome set on traditional Chinese medicine (COS-TCM) for chronic heart failure (CHF): a study protocol.
Zhang M; Chua HZ; Zhang J; Niu B; Zheng W; Li K; Zhang B
BMJ Open; 2021 Jul; 11(7):e047148. PubMed ID: 34215606
[TBL] [Abstract][Full Text] [Related]
10. Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Ma C; Panaccione R; Fedorak RN; Parker CE; Khanna R; Levesque BG; Sandborn WJ; Feagan BG; Jairath V
BMJ Open; 2017 Jun; 7(6):e016146. PubMed ID: 28601837
[TBL] [Abstract][Full Text] [Related]
11. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
[TBL] [Abstract][Full Text] [Related]
12. Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set.
Harman NL; Wilding J; Curry D; Harris J; Logue J; Pemberton RJ; Perreault L; Thompson G; Tunis S; Williamson PR;
Trials; 2018 Aug; 19(1):427. PubMed ID: 30086771
[TBL] [Abstract][Full Text] [Related]
13. Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement.
Mastacouris N; Tannenbaum R; Strunk A; Koptyev J; Aarts P; Alhusayen R; Bechara FG; Benhadou F; Bettoli V; Brassard A; Brown D; Choon SE; Coutts P; da Silva DLF; Daveluy S; Dellavalle RP; Del Marmol V; Emtestam L; Gebauer K; George R; Giamarellos-Bourboulis EJ; Goldfarb N; Hamzavi I; Hazen PG; Horváth B; Hsiao J; Ingram JR; Jemec GBE; Kirby JS; Lowes MA; Marzano AV; Matusiak L; Naik HB; Okun MM; Oon HH; Orenstein LAV; Paek SY; Pascual JC; Fernandez-Peñas P; Resnik BI; Sayed CJ; Thorlacius L; van der Zee HH; van Straalen KR; Garg A
JAMA Dermatol; 2023 Nov; 159(11):1258-1266. PubMed ID: 37755725
[TBL] [Abstract][Full Text] [Related]
14. Development of an international core outcome set for treatment trials in necrotizing enterocolitis-a study protocol.
Klerk DH; van Varsseveld OC; Offringa M; Modi N; Lacher M; Zani A; Pakarinen MP; Koivusalo A; Jester I; Spruce M; Derikx JPM; Bakx R; Ksia A; Vermeulen MJ; Kooi EMW; Hulscher JBF
Trials; 2023 May; 24(1):367. PubMed ID: 37259112
[TBL] [Abstract][Full Text] [Related]
15. Core outcome research measures in anal cancer (CORMAC): protocol for systematic review, qualitative interviews and Delphi survey to develop a core outcome set in anal cancer.
Fish R; Sanders C; Williamson PR; Renehan AG
BMJ Open; 2017 Nov; 7(11):e018726. PubMed ID: 29170292
[TBL] [Abstract][Full Text] [Related]
16. Development of reporting guidance and core outcome sets for seamless, standardised evaluation of innovative surgical procedures and devices: a study protocol for content generation and a Delphi consensus process (COHESIVE study).
Avery K; Blazeby J; Wilson N; Macefield R; Cousins S; Main B; Blencowe NS; Zahra J; Elliott D; Hinchliffe R; Potter S
BMJ Open; 2019 Sep; 9(9):e029574. PubMed ID: 31515426
[TBL] [Abstract][Full Text] [Related]
17. COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis.
Tallouzi MO; Mathers JM; Moore DJ; Murray PI; Bucknall N; Blazeby JM; Calvert M; Denniston AK
Trials; 2017 Dec; 18(1):576. PubMed ID: 29191216
[TBL] [Abstract][Full Text] [Related]
18. Development of an international core outcome set for treatment trials in paediatric inguinal hernia: protocol for a three-phase study including a systematic review and Delphi survey.
Maat SC; Gorter RR; van Heurn ELW; Rippen H; Butcher NJ; Offringa M; Derikx JPM
BMJ Open; 2023 Dec; 13(12):e077452. PubMed ID: 38097238
[TBL] [Abstract][Full Text] [Related]
19. Development of a Core outcome set for fetal Myelomeningocele (COSMiC): study protocol.
Altoukhi S; Whitehead CL; Ryan G; Deprest J; Joyeux L; Gallagher K; Drake J; Church P; Horn D; Diambomba Y; Carvalho JCA; Van Mieghem T
Trials; 2020 Aug; 21(1):732. PubMed ID: 32825852
[TBL] [Abstract][Full Text] [Related]
20. A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e-Delphi process and consensus meeting.
Langbroek GB; Wolkerstorfer A; Horbach SER; Spuls PI; Kelly KM; Robertson SJ; van Raath MI; Al-Niaimi F; Kono T; Boixeda P; Laubach HJ; Badawi AM; Rubin AT; Haedersdal M; Manuskiatti W; van der Horst CMAM; Ubbink DT;
Br J Dermatol; 2022 Nov; 187(5):730-742. PubMed ID: 35762296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]